NNSCF yields 1.28% · PFE yields 6.13%● Live data
📍 NNSCF pulled ahead of the other in Year 1
Combined, NNSCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNSCF + PFE for your $10,000?
NEC Networks & System Integration Corporation operates as a telecommunications infrastructure construction company in Japan and internationally. It operates through Digital Solutions Business, Network Infrastructures Business, and Engineering & Support Services Business segments. The Digital Solutions Business segment offers system integration services related to ICT platform and outsourcing/cloud services for business of enterprises and other customers, as well as solutions/services for customers' business transformation by using cutting-edge/digital technologies and contact center services. The Network Infrastructures Business segment provides system integration/services related to network infrastructures to telecom carriers, central and local governments, and social infrastructures service providers; and develops, manufactures, and sells network equipment. The Engineering & Support Services Business segment offers support services, such as maintenance and operations/monitoring related to ICT systems/services; and operations of company-wide service infrastructures. Its products include telephony servers, video conferencing systems, routers, switches, network testers, interface converters, load balancers, accelerators, Internet traffic, SSL-VPN access, firewalls, unauthorized access detection, authentication systems, operation and maintenance, spam blocking, physical security, log management, industry and task-specific applications, and software. NEC Networks & System Integration Corporation was incorporated in 1953 and is headquartered in Tokyo, Japan.
Full NNSCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.